ExPAND Mifepristone : Medical Management of Miscarriage and Abortion in FQHCs
The Annals of Family Medicine · 2023-09 · 21 (5) · 468-468
DOI: 10.1370/afm.3006 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Annals of Family Medicine, online erschienen am 26.04.2023. Verfasst von Lisa Wu und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Abortion, Spontaneous, Abortion, Induced. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Wu, L., Nutting, K., Harriett, L., McHugh, A., Janiak, E., & Stulberg, D. B. (2023). ExPAND Mifepristone : Medical Management of Miscarriage and Abortion in FQHCs. The Annals of Family Medicine, 21(5), 468-468. https://doi.org/10.1370/afm.3006
Vancouver
Wu L, Nutting K, Harriett L, McHugh A, Janiak E, Stulberg DB. ExPAND Mifepristone : Medical Management of Miscarriage and Abortion in FQHCs. The Annals of Family Medicine. 2023;21(5):468-468. doi:10.1370/afm.3006
BibTeX
@article{Wu2023,
author = {Wu, Lisa and Nutting, Kathryn and Harriett, Lauren and McHugh, Ashley and Janiak, Elizabeth and Stulberg, Debra B},
title = {ExPAND Mifepristone : Medical Management of Miscarriage and Abortion in FQHCs},
journal = {The Annals of Family Medicine},
year = {2023},
volume = {21},
number = {5},
pages = {468--468},
doi = {10.1370/afm.3006}
}
EUVIMED